| human | Q5 |
| P496 | ORCID iD | 0000-0003-0495-3848 |
| P108 | employer | Spanish National Center for Biotechnology | Q7573255 |
| P106 | occupation | researcher | Q1650915 |
| Q33576726 | A MATE-family efflux pump rescues the Escherichia coli 8-oxoguanine-repair-deficient mutator phenotype and protects against H(2)O(2) killing |
| Q37622415 | A non-canonical mismatch repair pathway in prokaryotes |
| Q30479277 | A novel role for RecA under non-stress: promotion of swarming motility in Escherichia coli K-12. |
| Q50424611 | Allele-Specific PCR Method Based on pncA and oxyR Sequences for Distinguishing Mycobacterium bovis from Mycobacterium tuberculosis: Intraspecific M. bovis pncA Sequence Polymorphism. |
| Q48029765 | An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection. |
| Q38626934 | Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth. |
| Q91364606 | Antibiotic-Induced Genetic Variation: How It Arises and How It Can Be Prevented |
| Q54444750 | Antibiotic-mediated recombination: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli. |
| Q77117010 | Antibiotic-selective environments |
| Q34334527 | Antibiotics and antibiotic resistance: a bitter fight against evolution. |
| Q24669682 | Autogenous and nonautogenous control of response in a genetic network |
| Q44958077 | Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase. |
| Q35819668 | Bleomycin increases amikacin and streptomycin resistance in Escherichia coli harboring transposon Tn5 |
| Q50193178 | Bleomycin-kanamycin resistance as a marker of the presence of transposon Tn5 in clinical strains of Escherichia coli. |
| Q86832377 | Bypass of genetic constraints during mutator evolution to antibiotic resistance |
| Q46135591 | Can Clays in Livestock Feed Promote Antibiotic Resistance and Virulence in Pathogenic Bacteria? |
| Q43572640 | Carcinoma of the penis. Our experience with 22 cases |
| Q41052192 | Cellular Response to Ciprofloxacin in Low-Level Quinolone-Resistant Escherichia coli |
| Q35897209 | Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. |
| Q28492940 | Characterization of the GO system of Pseudomonas aeruginosa |
| Q42021837 | Ciprofloxacin-Mediated Mutagenesis Is Suppressed by Subinhibitory Concentrations of Amikacin in Pseudomonas aeruginosa |
| Q54955873 | Clay-induced DNA breaks as a path for genetic diversity, antibiotic resistance, and asbestos carcinogenesis. |
| Q47102895 | Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases. |
| Q53772507 | Correction to 'Bypass of genetic constraints during mutator evolution to antibiotic resistance'. |
| Q39841639 | Cyclic AMP receptor protein positively controls gyrA transcription and alters DNA topology after nutritional upshift in Escherichia coli |
| Q37076747 | Determinants of Genetic Diversity of Spontaneous Drug Resistance in Bacteria |
| Q46886704 | Determination of the structure of a hybrid between 2-(1,4-benzoquinone)acetic acid and a linear peptide by electrospray ionization mass spectrometry. |
| Q91554328 | Effect of subinhibitory concentrations of ampicillin on Listeria monocytogenes |
| Q84517623 | Estimating mutation rates in low-replication experiments |
| Q38741337 | Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates. |
| Q50491788 | Exposure to diverse antimicrobials induces the expression of qnrB1, qnrD and smaqnr genes by SOS-dependent regulation. |
| Q93503771 | Genetic Characterization of Multidrug-Resistant Strains from a Hospital Outbreak Involving Human Immunodeficiency Virus-Positive Patients |
| Q38344584 | H-NS and RpoS regulate emergence of Lac Ara+ mutants of Escherichia coli MCS2. |
| Q54271627 | High Recombinant Frequency in Extraintestinal Pathogenic Escherichia coli Strains. |
| Q34508854 | High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. |
| Q54594290 | Hns mutant unveils the presence of a latent haemolytic activity in Escherichia coli K-12. |
| Q79162727 | Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance |
| Q42941702 | Identification of Nudix hydrolase family members with an antimutator role in Mycobacterium tuberculosis and Mycobacterium smegmatis. |
| Q60049273 | In silico identification and experimental validation of hits active against KPC-2 β-lactamase |
| Q72120888 | In-vitro synergy between aminoglycosides deployed against Staphylococcus spp. harbouring a 6'-aminoglycoside acetyltransferase, 2"-aminoglycoside phosphotransferase enzyme |
| Q54349119 | Influence of gene dosing on antibiotic resistance mediated by inactivating enzymes. |
| Q40738041 | Intrapopulation variability in mutator prevalence among urinary tract infection isolates of Escherichia coli. |
| Q44206898 | Laboratory diagnosis of antibiotic resistant Mycobacterium bovis within 48 h: a qualitative change in the approach to mycobacterial diseases in AIDS patients. |
| Q26853135 | Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance |
| Q50950504 | Molecular insights into fosfomycin resistance in Escherichia coli. |
| Q48224418 | Mutations in the aphA-2 gene of transposon Tn5 mapping within the regions highly conserved in aminoglycoside-phosphotransferases strongly reduce aminoglycoside resistance. |
| Q92130089 | N-acetylcysteine blocks SOS induction and mutagenesis produced by fluoroquinolones in Escherichia coli |
| Q40677243 | N-acetylcysteine selectively antagonizes the activity of imipenem in Pseudomonas aeruginosa by an OprD-mediated mechanism |
| Q35111741 | New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. |
| Q40612622 | Non-canonical mechanisms of antibiotic resistance. |
| Q57108909 | Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection |
| Q38309969 | PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa. |
| Q72561194 | PCR and hemodialysis patients |
| Q54242442 | Parallel Evolution of High-Level Aminoglycoside Resistance in Escherichia coli Under Low and High Mutation Supply Rates. |
| Q91037528 | Peptidoglycan recycling contributes to intrinsic resistance to fosfomycin in Acinetobacter baumannii |
| Q50093207 | Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC-2: A Step against Bacterial Resistance. |
| Q40368674 | Plasmidic qnr Genes Confer Clinical Resistance to Ciprofloxacin under Urinary Tract Physiological Conditions. |
| Q77107297 | Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients |
| Q42264036 | Quinolone Resistance Reversion by Targeting the SOS Response. |
| Q27641672 | Recognition and resistance in TEM beta-lactamase |
| Q40381942 | Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae. |
| Q40943537 | SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. |
| Q39474681 | Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure. |
| Q34003853 | Selection of very small differences in bacterial evolution. |
| Q37406333 | Side effects of antibiotics on genetic variability. |
| Q35111013 | Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases. |
| Q89869616 | Specificity and mutagenesis bias of the mycobacterial alternative mismatch repair analyzed by mutation accumulation studies |
| Q54118077 | Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. |
| Q57457985 | Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinolone-resistant Escherichia coli |
| Q90569983 | Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients |
| Q40401711 | Synergistic activity of fosfomycin, β-lactams and peptidoglycan recycling inhibition against Pseudomonas aeruginosa |
| Q40120435 | Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system. |
| Q28482375 | The Escherichia coli SOS gene dinF protects against oxidative stress and bile salts |
| Q41834172 | The Pseudomonas aeruginosa CreBC two-component system plays a major role in the response to β-lactams, fitness, biofilm growth, and global regulation. |
| Q33386642 | The Pseudomonas aeruginosa pfpI gene plays an antimutator role and provides general stress protection |
| Q41504155 | The antibiotic selective process: concentration-specific amplification of low-level resistant populations. |
| Q28492576 | The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants |
| Q58834967 | Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis |
| Q48179364 | Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake. |
| Q37023257 | Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli. |
| Q39651266 | Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations |
| Q77771580 | [Mechanisms of resistance to beta-lactam inhibitors of beta-lactamases] |
| Q73967925 | [Meropenem against bacteria carriers of wide spectrum TEM beta-lactamases: evolutive aspects] |
Search more.